Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

473
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
473
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

420
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
420
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

470
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
470
Autoimmune Disorders01:29

Autoimmune Disorders

1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

940
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
940

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Disseminated <i>Mycobacterium haemophilum</i> Infection Complicating Immunosuppressive Therapy in HLA-A29 Positive Birdshot Chorioretinopathy: Case Report.

Case reports in ophthalmology·2026
Same author

Blue Dacryorrhea After Inadvertent Infiltration of the Lacrimal Gland During Scleral Tattooing.

Cornea·2026
Same author

Comparative Outcomes of Exogenous and Endogenous MRSA Vs MSSA Endophthalmitis.

Ocular immunology and inflammation·2026
Same author

Imaging Biomarkers To Predict Progression of Intermediate AMD with Avascular Pigment Epithelial Detachment in the University of Colorado AMD Registry.

Research square·2026
Same author

Menopausal Hormone Therapy and Conversion from Intermediate to Advanced Age-Related Macular Degeneration.

Journal of vitreoretinal diseases·2026
Same author

Hypertensive Anterior Uveitis Following Intravitreal Faricimab.

Ocular immunology and inflammation·2026

相关实验视频

Updated: Jan 11, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.0K

多发性硬化症相关的脑膜炎成功控制了ofatumumab的使用.

Soufiane Azargui1, Julia L Xia1, Ian J McClain1

  • 1Department of Ophthalmology, University of Colorado School of Medicine, 1675 Aurora Court, F731, Aurora, CO, 80045, USA.

Journal of ophthalmic inflammation and infection
|November 14, 2025
PubMed
概括

在三名患者中,Ofatumumab有效治疗了多发性硬化症 (MS) 相关的脑膜炎. 这种B细胞疗法为MS患者的眼部炎症提供了一个有前途的自我治疗选择.

关键词:
这就是Kesimpta.多发性硬化症是多发性硬化症.这就是Ofatumumabumab.视网膜血管炎 视网膜血管炎排卵管炎 排卵管炎 是一种

更多相关视频

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.1K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K

相关实验视频

Last Updated: Jan 11, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.0K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.1K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K

科学领域:

  • 眼科医生 眼科 眼科
  • 神经学 神经学
  • 免疫学 免疫学 免疫学

背景情况:

  • 多发性硬化症 (MS) 可能与眼部炎症有关,特别是脑膜炎.
  • 目前用于MS相关的脑膜炎的治疗方法可能有局限性或需要复杂的管理.

研究的目的:

  • 报告ofatumumab在治疗多发性硬化症相关性脑膜炎的成功使用情况.
  • 突出ofatumumab作为MS相关的眼睛炎症的潜在治疗选择.

主要方法:

  • 介绍了MS相关性脑膜炎患者的三项病例研究.
  • 患者接受了ofatumumab治疗,结果通过临床检查和光素血管学 (FA) 监测.

主要成果:

  • 这三名患者都在眼部炎症方面显著改善,包括减少玻璃细胞和血管泄漏.
  • 一名患者从其他疗法成功过渡到ofatumumab,保持疾病静止.

结论:

  • 奥法图马布似乎是治疗多发性硬化症相关的多发性硬化症的有效治疗方法.
  • 由于ofatumumab的自我管理性质为患者提供了方便的优势.
  • 需要进一步的研究,以确定在MS相关的脑膜炎中ofatumumab治疗的最佳候选人.